← Back to all trials
Enrolling By Invitation
NCT07801339
Clinical Evaluation of Immediate Dental Implants in Very Elderly Patients.
Conditions: Tooth Loss / Rehabilitation
Sex: All
Ages: 80 Years – N/A
Enrollment: 15
Sponsor: Takane Dental Clinic
Location: Takane Dental Clinic Gotemba Shizuoka
Summary
Background: In recent years, dental implants have become a popular and effective option for replacing missing teeth, even in older adults. However, there is still limited research on implant treatments in patients aged 80 and older.
Study Details: In this study, we evaluated an 80+ year-old patient who requested dental implants after tooth extraction. The treatment involved placing an implant immediately after tooth removal, combined with bone grafting materials (Bio-Oss®) and cell-based regenerative therapy (Class III regenerative medicine). The patient continues to attend routine follow-up visits.
Goal: Because dental implants can greatly improve quality of life for elderly individuals, the goal of this study is to clinically evaluate the safety and effectiveness of implant therapy combined with regenerative medicine in patients aged 80 and older.
Eligibility Criteria
Inclusion Criteria:
* Patients aged 80 years or older requiring dental implant therapy following tooth extraction.
* Patients who desire dental implant treatment and provided written informed consent.
* Patients with sufficient systemic health to undergo minor oral surgical procedures.
* Patients willing and able to comply with scheduled follow-up visits and maintenance programs.
Exclusion Criteria:
* Uncontrolled systemic diseases (e.g., uncontrolled diabetes mellitus, severe cardiovascular disease) that contraindicate oral surgery.
* History of radiation therapy to the head and neck region.
* Current or past use of intravenous bisphosphonates or other medications associated with osteonecrosis of the jaw.
* Severe active periodontal disease in the remaining dentition.
* Heavy smokers or individuals with severe parafunctional habits (e.g., severe bruxism) that may jeopardize implant integration.
* Patients unable to attend regular follow-up appointments.
Source: ClinicalTrials.gov (NCT07801339). StuddyBuddy aggregates publicly available trial information.